ENVVENO MEDICAL CORP

Envveno Medical (NVNO) faces a steep decline yet sits near a 52‑week low—investors eye clinical milestones, peer moves and potential undervaluation for a strategic play.

Envveno Medical’s stock fell 4.81% to $6.91, hitting a 200‑day MA of $10.49 and trading $335k—mirroring a sector‑wide dip but still holding a $5.3M cap.